Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.39 |
| ▸ | CDC7 | O00311 | 1/20 | 0.39 |
| ▸ | TTK | P33981 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.37 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.37 |
| ▸ | TYRO3 | Q06418 | 8/20 | 0.36 |
| ▸ | MERTK | Q12866 | 8/20 | 0.36 |
| ▸ | AXL | P30530 | 7/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1051994 | 0.90 | PIK3CD (0.47) | GSK3BCDC7TTKPIK3CDPIK3CA | |
| SCHEMBL1046967 | 0.90 | PDPK1 (0.45) | GSK3BCDC7TTKTYRO3MERTK | |
| SCHEMBL1049573 | 0.88 | GSK3B (0.42) | GSK3BCDC7PDPK1CYP3A4DRD2 | |
| SCHEMBL1049579 | 0.85 | CDC7 (0.43) | GSK3BCDC7PDPK1CYP3A4DRD2 | |
| SCHEMBL1046970 | 0.84 | CDC7 (0.45) | GSK3BCDC7PDPK1CYP3A4DRD2 | |
| SCHEMBL1048478 | 0.84 | CDC7 (0.42) | GSK3BCDC7PIK3CDPIK3CGPDPK1 | |
| SCHEMBL1051833 | 0.84 | GSK3B (0.42) | GSK3BCDC7CYP3A4DRD2SLC6A2 | |
| SCHEMBL1051028 | 0.84 | CDC7 (0.48) | GSK3BCDC7TYRO3MERTKAXL | |
| SCHEMBL1049910 | 0.83 | CDC7 (0.42) | GSK3BCDC7PDPK1CYP3A4DRD2 | |
| SCHEMBL1051949 | 0.83 | GSK3B (0.42) | GSK3BCDC7TTKCYP3A4DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2454257-B1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | ABBVIE INC (US) | 2013-08-21 | — | — | EP | disclosed |
| US-8435980-B2 | Pyrrolopyridine inhibitors of kinases | ABBVIE INC. (US) | 2013-05-07 | — | — | US | disclosed |
| US-20110015173-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | ABBOTT LABORATORIES (US) | 2011-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015173-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | CDC7, MAP3K7, CDK1 | GSK3B 442/4885CDC7 1/4885TTK 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.